NCT04639817View on ClinicalTrials.gov

Trimethoprim-Sulfamethoxazole vs Levofloxacin as Targeted Therapy for Stenotrophomonas Maltophilia Infections: a Retrospective Cohort Study

CompletedOBSERVATIONAL
Enrollment

1,621

Participants

Timeline

Start Date

August 14, 2020

Primary Completion Date

January 31, 2021

Study Completion Date

April 27, 2021

Conditions
Stenotrophomonas Infection
Interventions
DRUG

Levofloxacin

Levofloxacin administration

DRUG

trimethoprim-sulfamethoxazole

Trimethoprim-sulfamethoxazole administration

Trial Locations (1)

20892

National Institutes of Health Clinical Center, Bethesda

Sponsors

Collaborators (1)

Duke University
All Listed Sponsors
collaborator

Duke University

OTHER

collaborator

Emory University

OTHER

lead

National Institutes of Health Clinical Center (CC)

NIH